Connect with us

Technology

MONTEFIORE EINSTEIN INVESTIGATORS DEMONSTRATE HOW A NEW SETTING FOR A DIGITAL MONITORING DEVICE CAN TRANSFORM DIABETES CARE

Published

on

New JAMA Network Open Study Highlights an Effective and Accessible Approach to Enhancing Diabetes Management

BRONX, N.Y., July 6, 2026 /PRNewswire/ — New research from Montefiore Einstein investigators reveals that an underutilized tool, more commonly employed by endocrinologists, can transform diabetes outcomes in primary care clinics. Despite a proven track record of improving diabetes management, only 10% of people with diabetes who need insulin use a Continuous Glucose Monitor (CGM) – a small wearable device that consistently tracks blood sugar levels.

Today, findings published in JAMA Network Open show that more than 2,000 patients who were prescribed CGMs were 13% less likely to require a hospital stay, 18% less likely to go to the emergency room and overall, experienced significant improvements in their blood sugar management compared to those not on CGMs. This analysis inspired new focus on increasing CGMs in primary care, centering around 18 Montefiore Medical Group (MMG) primary care clinics across Montefiore Medical Center.

“More than 40 million people in the U.S. are living with diabetes, so a creative and collaborative approach is needed to ensure people can access the tools that will help them successfully manage their condition,” said lead author Jovan Milosavljevic, M.D., M.S., endocrinologist and assistant professor of Medicine, Division of Endocrinology, Department of Medicine, Montefiore Einstein. “As an endocrinologist, I have seen firsthand the positive impacts of CGMs, and with people visiting their primary care doctors much more often, we have an incredible opportunity to empower primary care teams and our patients in this setting.”

Moving Beyond a Point in Time

The model that brought CGMs successfully from specialists to the primary care setting reflects efforts from senior author, Shivani Agarwal, M.D., M.P.H., senior director of Community Healthcare Improvement & Strategy at Montefiore Einstein, to redesign systems that shift care to the most appropriate settings, providing population health tools that are evidence-based and outcome-shifting.

“In healthcare, many of the challenges to improving outcomes stem from both having a system that isn’t built to support and optimize our incredible workforce, but also one that does not allow acceleration of paradigm-shifting advancements in medicine to translate quickly to our real-world care,” said Dr. Agarwal. “By initiating this primary care diabetes transformation to increase the use of CGMs in practice, I feel confident that we’ve identified a scalable model in an ideal setting where together, patients and clinicians are evolving how diabetes is managed. Diabetes affects our communities at high levels—we need to bring advancements like this to our patients quickly to improve their quality of life and outcomes.”

One of the challenges with diabetes is that the disease can require 24/7 care due to fluctuation of blood sugar levels, which are impacted by different foods consumed, physical activity, stress and certain medications. Prior to introducing CGMs, clinicians relied on data from finger pricks, which could be painful for patients and only represent a single point in time, while also relying on the patient coming to a clinic visit. CGMs, however, enable doctors and nurses to review data at the visit and remotely over time and see when exactly patients’ sugar levels spike or dip, leading to informed conversations about their diabetes and better access to care.

Supported in part by funding from the American Diabetes Association, Drs. Milosavljevic, Agarwal, and Hodgson are implementing a primary care clinic network-wide initiative where doctors are trained in CGM prescribing and management, staff nurses are being trained to apply and activate devices for patients in clinic, and patients not only are being educated on how to use the device and monitor the data, but are also helping to co-design how CGM patient support is built.

“People live with diabetes all day, every day, but when we were seeing these individuals in our clinics, we would just get one number, representing one moment in time,” said Sybil J. Hodgson, M.D., assistant vice president of Clinical Services, Montefiore Medical Group. “Having CGMs as a new tool at our disposal, we can ask questions about specific times where we saw blood sugar levels spike and dip, like if they had a certain meal then, or how they were feeling at the time. This has led to a deeper understanding of our patients’ lives and is enabling us to make treatment decisions based on a larger amount of actionable data points. This process is not only enabling patients to feel more active in managing their diabetes, it is also transforming how we treat one of the most prominent and persistent diseases seen in primary care.”

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems. It is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester, and the Hudson Valley. It comprises ten hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital, and over two hundred outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information, please visit www.montefiore.org. Follow us on Twitter, Instagram, and LinkedIn, or view us on Facebook and YouTube

View original content to download multimedia:https://www.prnewswire.com/news-releases/montefiore-einstein-investigators-demonstrate-how-a-new-setting-for-a-digital-monitoring-device-can-transform-diabetes-care-302816326.html

SOURCE Montefiore Health System

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

PerkinElmer and Covalent Announce Strategic Collaboration to Advance Failure Analysis and Materials Characterization for Semiconductor, Electronics, and Battery Industries

Published

on

By

Collaboration pairs PerkinElmer’s ICP-MS/MS and LC-MS/MS technologies with Covalent’s failure analysis expertise to help manufacturers pinpoint the root causes of material failure and performance degradation.

SHELTON, Conn. and SUNNYVALE, Calif., July 7, 2026 /PRNewswire/ — PerkinElmer and Covalent today announced a strategic collaboration to provide advanced analytical instrumentation and analysis services that address the growing complexity of failure analysis and materials characterization.

In the high-stakes fields of advanced electronics, semiconductor manufacturing, energy storage, and other precision-materials industries, identifying the root causes of material failures and performance drops is essential. Component degradation, trace chemical contamination, and structural breakdowns require highly sensitive analytical tools capable of detecting the smallest indicators of a larger problem.

Utilizing Inductively Coupled Plasma Mass Spectrometry (ICP-MS/MS) and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), researchers and manufacturers can track down ultra-trace elemental impurities and organic degradation mechanisms. These techniques optimize manufacturing quality control and accelerate root-cause failure analysis.

“This is an important partnership to help us better understand the analysis challenges facing the semiconductor, electronics, and battery industries,” said Paul Davies, Vice President, North America, PerkinElmer. “Covalent is a well-respected subject matter expert in this space and will be an invaluable voice of the customer, helping us push the boundaries of what ICP-MS/MS, LC-MS/MS, and other technologies in our portfolio are capable of in failure analysis, raw material characterization, and battery lifetime diagnostics.”

“PerkinElmer has been a trusted leader in analytical science for decades, and we are honored that they chose to partner with us for these critical applications,” said Craig Hunter, CEO of Covalent. “As materials systems and product designs become more complex, the ability to combine cutting-edge instrumentation with expert application knowledge is more important than ever. Our partnership with PerkinElmer will help customers gain deeper insight into the mechanisms that drive performance and reliability.”

PerkinElmer’s ICP-MS/MS delivers unmatched sensitivity for ultra-trace chemical analysis of metallic impurities before they deposit on silicon or compound-silicon wafers. The technique can also characterize the corrosion, solder joint deterioration, and migratory short-circuiting that cause modern printed circuit boards and electronic packages to fail.

PerkinElmer’s LC-MS/MS technology provides electrolyte degradation profiling for battery performance analysis and helps characterize the chemical degradation of coatings and epoxy mold compounds in electronic components. These same capabilities extend to impurity profiling, medical device characterization, and broader precision-materials work where chemical sensitivity is the binding constraint.

About PerkinElmer

PerkinElmer is a global leader in analytical and testing solutions, pharma specialty services, and omics solutions, serving customers across the life sciences, applied & industrial, and food. Drawing on nearly 90 years of pioneering innovation and engineering expertise, we support the science of our customers with insights of the highest standards of safety, quality and compliance for vital therapeutics, the integrity of the global food chain, the performance and sustainability of critical materials, and the sustainability of our environment. Together with scientists, laboratory and quality leaders, and manufacturing operators worldwide, our 5,500 colleagues in 35 countries empower progress by providing trusted insights and services for a healthier, safer, and more sustainable world.

For more information, visit: www.perkinelmer.com

Media Contact
Markus Leutert
VP, Corporate Communications & Sustainability

Markus.leutert@perkinelmer.com

About Covalent

Covalent is a leading materials characterization and failure analysis laboratory that helps companies solve complex engineering and manufacturing challenges. With expertise spanning semiconductor, electronics, battery, aerospace, medical device, and advanced materials industries, Covalent combines world-class scientific expertise with more than 100 analytical techniques to deliver actionable insights that improve product performance, reliability, and manufacturing quality. Learn more at www.covalent.com.

Media Contact
Sophia Attaf
Director of Marketing

marketing@covalent.com

View original content:https://www.prnewswire.com/news-releases/perkinelmer-and-covalent-announce-strategic-collaboration-to-advance-failure-analysis-and-materials-characterization-for-semiconductor-electronics-and-battery-industries-302819821.html

SOURCE Covalent

Continue Reading

Technology

Can $2,500 and a Smartphone App Double the Success of Sight-Restoring Surgery? New Orbis International Study Says Yes

Published

on

By

NEW YORK, July 7, 2026 /PRNewswire/ — A new study from global eye care nonprofit Orbis International, published today in the Bulletin of the World Health Organization, reveals a surprisingly simple solution to a major global health challenge. By combining a free smartphone app, focused on quality improvement, with a modest “micro-investment” of $2,500, 11 hospitals in Ethiopia nearly doubled their cataract surgery success rates, increasing the share of patients with good vision after surgery from 32.2% to 56.0% within months—a significant step toward the WHO’s global benchmark of 80%.

Cataract is the world’s leading cause of blindness, affecting 102 million people. While the surgery is inexpensive and straightforward, outcomes in low-resource settings are often mixed. Led by Orbis International, the BOOST Africa Study lays out a “blueprint for sight” that challenges conventional approaches in international development, showing how small, data-driven surgical fixes can be more effective than large infrastructure investments.

The “Diagnostic Discovery”

The study used the Better Operative Outcome Software Tool (BOOST), a free app that allows surgeons to track their surgical outcomes in real time. The data revealed a significant trend: the primary cause of poor vision after surgery wasn’t the surgeon’s lack of skill, but undetected co-morbidities like glaucoma or retinal disease.

“The app gave our partners in Ethiopia a mirror to see their own performance,” said Noelle Whitestone, co-author and Orbis International researcher. “We discovered that frequently it wasn’t the surgery failing; it was the screening. By providing just $2,500 per facility, hospitals were able to purchase specific diagnostic tools, such as indirect ophthalmoscopes, needed to identify the right patients for surgery. This result underscores that change doesn’t always require advanced technology—sometimes basic tools and skills are enough.”

A Tale of Two Countries: The Zambia Lesson

The study also provides a rare, candid look at the logistical “last mile” of global health. While Ethiopia saw rapid success, five partner hospitals in Zambia faced significant delays due to procurement and supply chain hurdles.

“Our work in Zambia shows that data is a powerful diagnostic tool for a surgical team, but its value is realized only when the infrastructure supports them,” said Whitestone. “When a surgeon identifies a specific need through the app, we must ensure they have the administrative and financial backing to secure the necessary equipment and training. This study confirms that for digital health to be effective, it must be paired with funding that responds to the surgeon’s own findings.”

A Scalable Model for 2030

As the world strives to meet the WHO 2030 targets for eye care, the BOOST Africa Study offers a cost-effective, high-tech roadmap. By using e-health tools to standardize quality, even the most remote clinics can achieve high-level results. The BOOST app empowers surgeons to track their own results over time, compare outcomes with peers globally, and identify areas for improvement in a supportive, non‑threatening, data‑driven environment. By translating performance data into practical, actionable feedback, the platform opens new opportunities for skills exchange, continuous learning, and sustained improvements in surgical quality.

This study was funded by the Lions Clubs International Foundation.

About Orbis International

Orbis International works around the world to prevent blindness and restore sight for children and adults in places where eye care is out of reach—so vision problems don’t make it harder to learn, earn a living, or enjoy life. Around 1.1 billion people live with vision loss, but with the right care, 90% of it is completely avoidable. That is why Orbis trains doctors, nurses, and other eye care professionals to provide care in their own communities—and works to make sure people of all ages can access the eye exams, glasses, medicine, and surgeries they need to protect and restore their sight. Orbis began this work more than 40 years ago with the Flying Eye Hospital, a teaching hospital on a plane that brings expert training and care where they’re needed most. Today, we also work with local hospitals and clinics across Africa, Asia, and Latin America to make eye care available to more people, and we use and develop technology—like our award-winning Cybersight e-learning and telehealth platform, artificial intelligence screening, and virtual reality training—to help eye care teams treat patients more effectively. Orbis ranks in the top 3% of U.S. charities, having earned top marks for transparency and accountability from Charity NavigatorGuideStar, and the Better Business Bureau. To learn more, please visit orbis.org.

About the BOOST App

The Better Operative Outcome Software Tool (BOOST) is a free, user-friendly app that helps cataract surgical providers monitor and improve their results. Developed by Orbis and a global consortium, it is available on Android and Windows to help hospitals everywhere achieve excellence in eye care.

MEDIA CONTACT
Jenna Montgomery
Interim Lead, Global Communications and Marketing
jenna.montgomery@orbis.org 

SOURCE Orbis International

Continue Reading

Technology

In HelloNation, Luxury Real Estate Expert Jud Whitlock Explains Why Local Expertise Still Wins in a Global Luxury Market

Published

on

By

The article examines how neighborhood knowledge helps buyers and sellers make informed decisions in an increasingly connected luxury real estate market.

ATLANTA, July 7, 2026 /PRNewswire/ — Why does local expertise matter in luxury real estate? A recent HelloNation article answers this question, featuring insights from Luxury Real Estate Expert Jud Whitlock of Atlanta Fine Homes/Sotheby’s International Realty. In a HelloNation article, Whitlock, a 3rd-generation Atlantan, discusses why, despite the rise of global exposure and online access, local knowledge remains the defining advantage in high-end real estate. His analysis shows that understanding the nuances of a community continues to separate good investments from great ones.

The article explains that while the modern luxury market is increasingly international, success still depends on localized understanding. Buyers can now explore properties across the world with a few clicks, but they rely on professionals who know the rhythms, people, and history of a city. Whitlock notes that in Atlanta, this knowledge makes a tangible difference. Agents who live and work in the community can interpret data in context, identifying factors that numbers alone cannot show.

Local expertise, he explains, goes beyond familiarity with listings. It involves recognizing the subtle shifts that define value over time. A home’s orientation, elevation, and surrounding development can all influence its performance. Professionals with local roots can read these details intuitively, guiding clients with precision rather than guesswork. They understand how market conditions fluctuate with the seasons and how cultural or lifestyle patterns affect demand.

Whitlock highlights that both buyers and sellers gain significantly from this level of insight. For buyers, local professionals identify homes that align with both lifestyle and investment goals. They anticipate practical concerns such as commute routes, community restrictions, or long-term maintenance requirements. This perspective helps clients make decisions grounded in reality, avoiding costly surprises. For sellers, local agents know how to position properties strategically, choosing the right timing, presentation, and pricing for maximum impact.

Global marketing networks remain valuable, but Whitlock stresses that global reach must be supported by local understanding. A property can attract international attention, yet its success depends on how it is represented within its immediate environment. The strongest agents bridge these two worlds, using global tools alongside neighborhood-level insight. Whitlock explains that this combination allows listings to reach broad audiences while maintaining authenticity and precision.

Atlanta’s luxury market provides a clear example of this balance. From Buckhead’s historic estates to the mountain retreats of North Georgia, each area reflects its own culture and buyer profile. Global exposure can draw attention to these listings, but only a local expert can interpret the subtleties of value between communities. Whitlock observes that knowing how design, location, and lifestyle interact is what allows agents to serve clients effectively across price ranges and regions.

Local professionals also bring a deep understanding of zoning, taxes, and regional development that global data cannot capture. Whitlock points out that this awareness allows agents to advise clients on growth areas, infrastructure improvements, and neighborhood stability. Such insights turn single purchases into informed, long-term investments. The most successful advisors use this foresight to help clients build wealth and confidence in an evolving market.

Relationships further strengthen the advantage of local representation. Whitlock emphasizes that trusted connections with inspectors, contractors, and designers ensure quality at every stage of the transaction. Local networks simplify repairs, staging, and closing procedures. These partnerships create a seamless experience that builds trust among buyers and sellers alike. The consistency and accountability developed through local collaboration set a high standard of service that benefits the entire community.

For international buyers entering Atlanta’s market, Whitlock explains that local guidance provides cultural and procedural clarity. Real estate practices vary around the world, from negotiation styles to closing timelines. Local experts act as interpreters, explaining how the Atlanta market functions and how its values differ from other regions. This insight gives foreign investors the confidence to act quickly and wisely, supported by a professional who understands both global expectations and local realities.

While technology has transformed how buyers discover properties, Whitlock notes that it cannot replace the human insight that local professionals bring. Virtual tours and online data reveal only part of the story. Understanding what those metrics mean within the context of a specific street, neighborhood, or school district requires lived experience. Local expertise makes digital tools more effective by grounding them in a firsthand perspective.

The most successful transactions, according to Whitlock, combine global exposure with local depth. This partnership ensures that wide visibility is matched by credibility and precision. Homes marketed through international platforms attract attention, but those represented with authentic neighborhood insight inspire confidence. In a competitive market, this balance gives both buyers and sellers an enduring advantage.

Atlanta’s continued rise as a global destination underscores the value of local expertise. Whitlock concludes that no matter how advanced technology becomes, the human element remains at the heart of real estate. Advisors who understand both the world and their own city deliver the results that matter most. In an age of digital convenience, local knowledge keeps the process grounded, informed, and deeply personal.

Why “Local Expertise” Still Wins in a Global Luxury Market, features insights from Jud Whitlock, Luxury Real Estate Expert of Atlanta, Georgia, in HelloNation.

About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/in-hellonation-luxury-real-estate-expert-jud-whitlock-explains-why-local-expertise-still-wins-in-a-global-luxury-market-302819846.html

SOURCE HelloNation

Continue Reading

Trending